Insider · SEC Form 4 filer
Robert Cascella
Companies
Where they file as an insider
KORU Medical Systems (KRMD) Director Latest filing Oct 1, 2026
Celestica (CLS) Director Latest filing Sep 30, 2026
Neuronetics (STIM) Director Latest filing May 28, 2026
Mirion Technologies (MIR) Director Latest filing May 13, 2026
Track record
Did their buys beat the typical stock?
Open-market buys6
Quarters checked 6 months later1
Beat the typical stock —
Quarters too new to check0
Too soon to tell. 1 quarter has finished so far. We show a record once 3 have.
Neuronetics (STIM) Bought Aug 14–Sep 12, 2024 · $175K · 209,000 shares Not counted Not counted. We have no fund price for this stock on both Sep 30, 2024 and Mar 31, 2025.
Neuronetics (STIM) Bought Jun 6, 2024 · $102K · 50,000 shares Behind typical Jun 30, 2024 $1.80 → Dec 31, 2024 $1.61 · −10.6% (typical stock +3.9%)
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.